Elbasvir–grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial
…, R Nahass, CY Peng, B Conway… - Annals of internal …, 2016 - acpjournals.org
… Conway reports grants, personal fees, and nonfinancial support from Merck, AbbVie, and
Gilead outside the submitted work. Dr. Grebely reports grants from AbbVie, BMS, Gilead, and …
Gilead outside the submitted work. Dr. Grebely reports grants from AbbVie, BMS, Gilead, and …
[BOOK][B] Electrochemical supercapacitors: scientific fundamentals and technological applications
BE Conway - 2013 - books.google.com
The first model for the distribution of ions near the surface of a metal electrode was devised
by Helmholtz in 1874. He envisaged two parallel sheets of charges of opposite sign located …
by Helmholtz in 1874. He envisaged two parallel sheets of charges of opposite sign located …
Transition from “supercapacitor” to “battery” behavior in electrochemical energy storage
BE Conway - Journal of the Electrochemical Society, 1991 - iopscience.iop.org
The storage of electrochemical energy in battery," supercapacitor," and double-layer
capacitor devices is considered. A comparison of the mechanisms and performance of such …
capacitor devices is considered. A comparison of the mechanisms and performance of such …
Electrochemical oxide film formation at noble metals as a surface-chemical process
BE Conway - Progress in surface science, 1995 - Elsevier
The mechanisms of electrochemical oxide film formation at noble metals are described and
exemplified by the cases of Pt and Au, especially in the light of recent experimentation by …
exemplified by the cases of Pt and Au, especially in the light of recent experimentation by …
The role and utilization of pseudocapacitance for energy storage by supercapacitors
BE Conway, V Birss, J Wojtowicz - Journal of power sources, 1997 - Elsevier
The principle of utilizing the non-Faradaic double-layer capacitance of electrode interfaces
as a means of storing electrical energy was suggested and utilized in technologies initiated …
as a means of storing electrical energy was suggested and utilized in technologies initiated …
[HTML][HTML] Antiretroviral-drug resistance among patients recently infected with HIV
…, JW Mellors, E Connick, B Conway… - … England Journal of …, 2002 - Mass Medical Soc
Background Among persons in North America who are newly infected with the human
immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has …
immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has …
Ionic hydration in chemistry and biophysics
BE Conway - 1981 - osti.gov
Introductory chapters on topics required for the discussion of ionic solutions in water and
other solvents are included; eg sections on elements of electrostatics, dielectric polarization …
other solvents are included; eg sections on elements of electrostatics, dielectric polarization …
[HTML][HTML] Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection
…, C Cooper, WJ Towner, B Conway… - … England Journal of …, 2015 - Mass Medical Soc
Background In phase 2 trials, treatment with the combination of the nucleotide polymerase
inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained …
inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained …
[BOOK][B] Modern aspects of electrochemistry
JOM Bockris, BE Conway, RE White - 2012 - books.google.com
… Department of Chemistry Texas A&M University College Station, Texas BE CONWAY …
Conway, BE (Series: Modern aspects series of chemistry) … Bockris Texas A&M University …
Conway, BE (Series: Modern aspects series of chemistry) … Bockris Texas A&M University …
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial
…, P Reiss, D Cooper, S Vella, M Harris, B Conway… - Jama, 1998 - jamanetwork.com
Context.—Current guidelines recommend that individuals infected with the human
immunodeficiency virus type 1 (HIV-1) be treated using combinations of antiretroviral agents to …
immunodeficiency virus type 1 (HIV-1) be treated using combinations of antiretroviral agents to …